Hooks Corwin Dale has filed 6 insider transactions across 2 companies since April 2024.
Most recent transaction: a grant/award of 11000 shares of SPRUCE BIOSCIENCES, INC. ($SPRB) on March 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | SPRUCE BIOSCIENCES, INC. | $SPRB | Hooks Corwin Dale | Chief Commercial Officer | A | Restricted Stock Units | 11000 | $0.00 | 11,000.0000 | 1,070,370 | 9999.99% | 1.03% |
| Dec. 19, 2025 | Applied Therapeutics, Inc. | $APLT | Hooks Corwin Dale | Chief Commercial Officer | A | Common Stock | 312500 | $0.00 | 868,253.0000 | 145,559,604 | 56.23% | 0.21% |
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Hooks Corwin Dale | Chief Commercial Officer | D | Common Stock | 862500 | $0.00 | 5,753.0000 | 145,559,604 | 99.34% | 0.59% |
| Feb. 3, 2026 | Applied Therapeutics, Inc. | $APLT | Hooks Corwin Dale | Chief Commercial Officer | U | Common Stock | 5753 | $0.00 | 0.0000 | 145,559,604 | 100.00% | 0.00% |
| March 24, 2025 | Applied Therapeutics, Inc. | $APLT | Hooks Corwin Dale | Chief Commercial Officer | A | Common Stock | 250000 | $0.00 | 550,000.0000 | 139,534,746 | 83.33% | 0.18% |
| April 12, 2024 | Applied Therapeutics, Inc. | $APLT | Hooks Corwin Dale | Chief Commercial Officer | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 84,244,494 | 9999.99% | 0.36% |